EUROPACE, cilt.9, sa.5, ss.270-274, 2007 (SCI-Expanded)
Aim Implantable cardioverter defibrillators (ICD) reduce arrhythmic mortality in a wide range of patients with poor left ventricular (LV) function. However, whether ICD therapy is equally effective in younger and older patients remains uncertain. To address this question, we compared ICD-documented ventricular tachyarrhythmia burden in patients < 75 years of age (Group 1) and >= 75 years of age (Group 2).